Le Lézard
Classified in: Health, Business
Subjects: PDT, SVY, OTC

Sugarmade Announces BudLife Intelligent Cannabis Container System White Paper


CITY OF INDUSTRY, California, June 27, 2017 /PRNewswire/ --

Sugarmade, Inc. (OTCQB:SGMD), today announces the publication of a White Paper on intelligent cannabis storage and its upcoming product, BudLife, the first container system expected to maintain the integrity of cannabis for up to six months.

Medical Marijuana is currently being dispensed through a wide variety of legacy packaging methods, including various types of bottles and bags. None of these packaging methods are capable of defeating infectious bacteria or disease, nor do they increase shelf life or help to maintain potency. Sugarmade, Inc, (OTCQB:SGMD) and its partner, Plantation Corp, are the pioneers and innovation leaders in the development of intelligent container systems customized to meet the special needs of the fast growing legal cannabis industry. The mission is to create, manufacture and market the first container system that maintains the integrity of this plant for up to six months. Called BudLife, this patented product represents a quantum breakthrough in the science of marijuana preservation and delivery.

Jimmy Chan, CEO of Sugarmade commented, "We have posted the new White Paper to inform our investors on the progress we have made on the Intelligent Cannabis Container System and to inform the industry about the market dynamics of cannabis storage. Protected by strong patents, the cannabis container systems being developed will be unique, and cannot be copied or replicated by a competitor. Sugarmade has been exclusively granted exclusive distribution of the products to what the Company believes is the single largest cannabis consumer market, the U.S. states of California, Oregon and Washington.

The White Paper, titled, "Cannabis Storage - The Active Packaging Market Opportunity and Technical Requirements" can be accesses at http://bit.ly/2sQnqw1 . Additional information can be seen at the new website at http://www.BudLife.net.

FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" and other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements.  

Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

For inquiries please contact Jimmy Chan at +1(888)-982-1628 or [email protected].

SOURCE Sugarmade, Inc.


These press releases may also interest you

at 00:16
WestGene, a biotech company dedicated to mRNA technology, announces a historic milestone with the FDA IND approval of its mRNA therapeutic cancer vaccine, WGc-043. This landmark achievement marks the world's first approval of an EB virus-related mRNA...

at 00:00
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer nanoparticle anticancer under clinical trial. SNB-101...

9 mai 2024
TCI Group is proud to be participating in Phase 1 of the Alliance for Water Stewardship (AWS) Impact Accelerator. Together we are working in Shanghai Jinshan with AWS Members and five other facilities to expand our knowledge, skills and networks to...

9 mai 2024
A research team led by The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded approximately $11 million over five years by the National...

9 mai 2024
Celltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale acquisition cost (WAC). Adalimumab-aaty will be...

9 mai 2024
Rakuten Medical, Inc., a global...



News published on and distributed by: